Advisory Board Dr. Barry Bloom, Harvard University Distinguished Service Professor & Past Dean Harvard School of Public Health George Bickerstaff, Managing Director, CRT Capital Group William W.Chin,M.D., Vice President Discovery Research, Eli Lilly & Company Venkat Jasti, Chairman & CEO, Suven Lifesciences Dr. Ismail Kola, Sr. Vice President & CSO, Schering Plough Reid Leonard, Executive Director, Merck & Co. Dr. Peter Mueller, Executive Vice President & CSO, Vertex Pharmaceuticals CSN Murthy, CEO, Aurigene Discovery Dr. Michael Rosenblatt, Dean, Tufts University School of Medicine Dr. K.V. Subramaniam, CEO, Reliance Life Sciences Dr. Sridaran Natesan, PhD, Co-Leader - Stem Cell Initiative, Sanofi-avntis Dr. Gunther Winkler, Sr. Vice President, Biogen Idec
Program Schedule (Program & Timings subject to change)
12-30 PM 1-00 PM: Registration
1-00 PM 1-10 PM: Welcome address remarks by Karun Rishi, President-USA-India Chamber of Commerce
1-10 PM 1-35 PM: Release of Annual Position Paper by Dr. Martin Mackay
McKinsey & Company presentation of USA-India Chamber of Commerce commissioned annual Position Paper
1-35 PM 2-30 PM: Panel Discussion: Healthcare, Clinical Research and Industry-Academic Partnerships
Panelists: Dr. Gerald Keusch, Associate Provost, BU School of Public Health, Dr. David Lacey, Senior Vice President & Head of Research, Amgen, Dr. Michael Rosenlatt, Dean Tufts University School of Medicine, Joe Smith, MD, PhD, Vice President-Emerging Technologies, Johnson & Johnson, Sridhar Mosur, Chief Executive Officer, Jubilant Biosys
Moderator: Dr. William Chin, Vice President - Discovery Research & Clinical Investigation, Eli Lilly & Company
Introduction: Manni Kanti Pudi, President, GVK BioSciences
2-30 PM 2-55 PM: Keynote Address by Martin Mackay, President, Pfizer Global Research & Development
Panelists: K.V.Subramaniam, President & CEO, Reliance Life Sciences; Jeff Collins, Executive in Residence, Pappas Ventures; Jeffrey Elton, Life Sciences Investor & Consultant; George Bickerstaff, Managing Director, CRT Investment Banking; Shrikumar Suryanarayan, Director General, ABLE
Moderator: Glen Giovanneti, Global Biotechnology Leader, Ernst & Young
Introduction: Banashri Bose Harrison, Minister (Commerce), Embassy of India
3-50 PM 4-20 PM: Networking and Tea Break
4-20 PM 4-45 PM: Keynote Address by Nobel Laureate Dr. Sidney Altman
4-45 PM 5-05 PM: Presentation by Department of Pharmaceuticals, Govt of India. Paresh Johri, Deputy Secretary
5-05 PM 6-00 PM: Panel Discussion: Drug discovery, Development and Collaborative Research
Panelists: Robert Armstrong, PhD, Vice President, Global External R&D, Eli Lilly; Venkat Jasti, Chairman & CEO, Suven Life Sciences; Ismail Kola, PhD, Senior Vice President- Discovery Research & Chief Scientific Officer, Schering-Plough; CSN Murthy, Chief Executive Officer, Aurigene Discovery; Dr. John Thompson, Vice President, Strategic Research Alliances, Vertex
Moderator: Ramesh Srinivasan, Principal, McKinsey and Company
Introduction by Dr. Gerald Keusch, Associate Provost, BU School of Public Health
Award Presentation by Dr. Martin Mackay and Karun Rishi
Address by Dr. Barry R. Bloom, Harvard University Distinguished Service Professor and Joan L. and Julius H. Jacobson Professor of Public Health at the Department of Immunology and Infectious Diseases, Harvard School of Public Health
6-25 PM 6-35 PM: Closing Remarks - James Mullen President & CEO, Biogen Idec
6-35 PM 8-00 PM: Cocktails and Networking Reception - Charles View Ballroom, 16th Floor
Cocktails and Networking Reception
Highlights
Annual high profile summit of established and emerging Biotech, Pharmaceuticals, Medical Devices, Healthcare companies form the US and India, Venture Capitalists, Investment Bankers, Policy Makers and Academia
THE Bio Pharma event in the world focused on US-India BioPharma, Medical Devices and Healthcare
Access to key people focused on US-India BioPharma & Healthcare and top tier investors
An ideal opportunity to enhance corporate visibility to people who matter
Large participation by CEOs, Chief Scientific Officers and Chief Medical Officers of large and emerging Bio, Pharma, Medical Devices and Healthcare companies
Participation by senior partners of top tier Life Sciences/Healthcare Venture Capitalist, Investment Bankers and Private Equity firms
A forum open only to senior executives
* Program and speakers subject to change
Registration fee: $750. Limited seats available. Registration fee subject to change. No walk-ins or at the door registration. Register now USA-India Chamber of Commerce reserves the right to decline a registration without assigning any reason.
Summit open only to Senior Biotech/Pharma/Medical-Devices/Healthcare Executives, Enterpreneurs, Venture Capitalists, Investment Bankers, Private Equity Firms, Policy makers and Academia.
Jainder Singh, Secretary, Department of IT, Ministry of Communications & IT
Siddhartha Behura, Secretary, Department of Telecom, Ministry of Communications & IT
Tejendra Khanna, Lt. Governor Delhi
Chief Minister, Government of Karnataka
Katta Naidu, Minister of IT/BT and Revenue, Government of Karnataka
Secretary- Information Technology, Development Commissioner (Industries), Member Secretary Maharashtra Biotechnology Commission, Government of Maharashtra
Industry, Industry organizations, State and Federal officials in the US
1-30 PM 2-00 PM: Registration Master of Ceremonies: Hon. Andrew Maguire, PhD, Executive Director-GAVI 2-00 PM 2-10 PM: Welcome address and opening remarks by Karun Rishi, President USA-India Chamber of Commerce 2-10 PM 2-30 PM: McKinsey & Company presentation of USA-India Chamber of Commerce annual Position Paper 2-35 PM 3-25 PM: Panel Discussion: Drug Discovery, Collaborative Research and Strategic Alliances Panelists: Dr. William Chin, Vice President - Discovery Research, Eli Lilly Venkat Jasti, Vice Chairman & CEO, Suven Life Sciences Dr. Peter Mueller, Exe. Vice President & CSO, Vertex Pharmaceuticals Barbara Yanni, Chief Licensing Officer, Merck & Co. Dr. Rashmi Barbhaiya, Co-Founder and CEO, Advinus Therapeutics 3-30 PM 3-55 PM: Official Release of Position Paper and Keynote address by Honorable Kapil Sibal, Minister of Science & Technology and Earth Sciences, Government of India * 3-55 PM 4-25 PM: Networking and Tea Break 4-25 PM 5-15 PM: Panel Discussion: Funding Innovation, Investment Opportunities, Cross Border M&A trends Panelists: Frederick Frank, Vice Chairman & Director, Lehman Brothers Dr. Helmut M. Schühsler, Managing Partner, TVM Capital Tom Andrews, Senior Vice President, Alexandria Real Estate Equities Sri Mosur, President & CEO, Jubilant Biosys Ltd. Dr. Jasmin Patel, Managing Director, Fidelity Capital Management (India) 5-15 PM 5-40 PM: Keynote address by Dr. Surinder Singh, Drug Controller General of India * 5-40 PM 6-00 PM: Introduction: James Mullen, President & CEO, Biogen Idec and past Chairman, Biotechnology Industry Organization (BIO)
Keynote address by Dr. Joshua Boger, President & CEO, Vertex Pharmaceuticals and Chairman, Biotechnology Industry Organization (BIO) 6-00 PM 6-50 PM: Panel Discussion: Drug Development & Manufacturing, Clinical Research and In/Out Licensing Panelists: Dr. Mark Powell, Sr VP & Worldwide Head-Pharmaceutical Development, Bristol Myers & Squibb Gregg Alton, Senior Vice President, Gilead Sciences Dr. Gunther Winkler, Sr. Vice President, Biogen Idec Dr. Arun Chandavarkar, Chief Operating Officer, Biocon Ltd. Dr. Dianne Kikta, Vice President Global Clinical, Wyeth Dr. Sreeni Devidas, Vice President, GVK BioSciences 6-50 PM 7-00 PM: Closing Remarks Dr. Helmut M. Schühsler, Managing Partner, TVM Capital and Board Member, USA-India Chamber of Commerce 7-00 PM 8-30 PM: Cocktails and Networking Reception Charles View Ballroom, 16th Floor
2007 Summit was sold out. Over 300 senior executives participated, Release of Position Paper on Indian Bio-Pharma industry. See 2007 Summit details
Great opportunity to meet US-India focused established and emerging Bio-Pharma companies and investors in one location
High power networking reception
An excellent opportunity to connect for Partnership, Selling, Sourcing, Financing and M&A
Media Partners
Sponsors
Department of Biotechnology Ministry of Science & Technology Government of India
Knowledge Partner:
Industry Partner:
US India Biotech Summit - 2007
Monday, May 7, 2007. 5:00 pm - 9:00 pm Hotel Omni Parker House 60 School Street, Boston, MA 02108, USA
5-00 pm 5-15 pm: Registration 5-15 pm 5-30 pm: Summit inauguration and remarks by James C. Mullen, Chairman Biotechnology Industry Organization (BIO), CEO & President, Biogen Idec 5-30 pm 5-45 pm: Welcome address and opening remarks by Karun Rishi, President, USA-India Chamber of Commerce Release of USA-India Chamber of Commerce-Ernst & Young Position Paper on Indian Biotech industry 5-45 pm - 6-30 pm: Panel Discussion (1): Discovery, Development, IP & Regulatory Issues Panelists: Dr. Alan Smith, Chief Scientific Officer, Genzyme Dr. Peter Mueller, Chief Scientific Officer, Vertex Pharmaceuticals Dr. Rashmi H.Barbhaiya, CEO and MD, Advinus Therapeutics Dr. Sridhar Mosur, Managing Director, Jubilant Chemsys Ltd Dr. Arun Chandavarkar, Chief Operating Officer, Biocon Ltd.
Moderator: David C U'Prichard, PhD, Partner, Red Abbey Venture Partners and Care Capital
6-45 pm - 7-30 pm: Panel Discussion (2): Investment Opportunities, Cross Border Investments, and M&A Trends in the Life Sciences industry (US-India)
Panelists: Dr. Helmut M. Schühsler, Managing Partner, TVM Capital Dr. David Gluckman, MD & Head of European Life Sciences, Lazard George Bickerstaff, Managing Director, CRT Capital Group Hari Bhartia, Co-Chairman & MD, Jubilant Organosys Ltd Dr. Stephen Knight, Managing Partner, Fidelity Biosciences Moderator: Utkarsh Palnitkar , Partner-Transaction Advisory Services, Industry Leader - Health Sciences, Ernst & Young
Closing remarks: Dr. Helmut M. Schühsler, Managing Partner, TVM Capital and Board Member, USA-India Chamber of Commerce
7-30 pm- 9 pm:Cocktails & Networking Reception
Media Partners
The Deal's BRIC Symposium
April 12, 2007 Agenda & Registration Location: The Westin New York at Times Square USA-India Camber of Commerce is the Association Partner of BRIC Symposium. USAIC members save 15% off the The Deal's BRICs Symposium.
M&A and Investment opportunities in key emerging economies continue to thrill and terrify US professionals. In this one-day symposium, an audience of bankers, strategic acquirers, private equity partners and other alternative investment will gather in New York to hear the strategies and perspective of the leading investors and dealmakers who are having significant success currently in Brazil, Russia, India and China (BRIC).
India Healthcare Luncheon Business Roundtable
India Healthcare Luncheon Business Roundtable with Dr. Anbumani Ramadoss, Honorable Union Minister of Health, Government of India and Prof. N.K. Ganguly, Director General, Indian Council of Medical Research (ICMR).
Opening remarks: Prof. Barry R. Bloom, Dean, Harvard School of Public Health Remarks: Karun Rishi, President, USA-India Chamber of Commerce Q&A and open discussion
Date: Friday, March 30, 2007 Time: 12 pm - 2 pm
Location: Harvard Faculty Club, Cambridge, MA
Opportunities in the Indian Healthcare industry
Opportunities in India for US Healthcare, Biotech, Pharma and Medical Device companies
Public-Private partnership in Indian Healthcare
Business Roundtable open to C level and senior executives from Healthcare, Pharma, Biotech, Medical Devices, Investment firms and Academia.
Event is complementary for members.
India Business Summit
Special focus on opportunities for US SME companies in India. The two day conference besides several keynotes will have sessions on IT, ITeS, Retail, Real Estate, Food Processing, Auto and Auto Components, Financing, Entrepreneurship, Policy, Market Access, Emerging sectors and Export opportunities.
Senior policy makers and key executives from Walmart, Citigroup, Bank of America, SBA, Coca-Cola, Kelloggs, Tishman Spyer, Parsons, IBM, Hero Group, UPS, Bharti, General Motors, EXIM Bank, and Proctor & Gamble etc will participate in the panel discussions.
Place: Maurya Sheraton Hotel, New Delhi, India
Date: Jan 23-25, 2007
India Healthcare Business Roundtable
Opening Remarks: Karun Rishi, President, USA-India Chamber of Commerce
Remarks by Prof K. Srinath Reddy, Professor and Head, Department of Cardiology, All India Institute of Medical Sciences (AIIMS) and President, Public Health Foundation of India
Remarks by Prof. Barry R. Bloom, Dean, Harvard School of Public Health
Q&A and open discussion
Closing Remarks: Stephen Knight, Managing Partner, Fidelity Biosciences
Date: Wednesday, December 6, 2006 Time: 12:00 p.m.-2:00 p.m.
Location: Downtown Harvard Club Boston, Massachusetts
The discussion will focus on:
Opportunities for US Pharma, Biotech and Medical Device companies
Public-Private partnership in healthcare
Public Health Foundation of India
AIIMS research initiatives in electrophysiology, cardiomyopathies, gene therapy and stem cell therapy
Prof Reddy was recently appointed President of the Public Health Foundation of India. Dr. Reddy Chairs numerous healthcare commissions and committees in India and internationally.
Exciting things are happening in Indias healthcare sector. Industry, Academia, Research institutions and Investors in the US need to take a serious look at India opportunity.
This roundtable is only for senior executives.
Event is complementary for members.
BUSINESS DEVELOPMENT MISSION TO INDIA November 29 to December 5, 2006
USA-India Chamber of Commerce is pleased to support the Business Development Mission led by Amb. Franklin L. Lavin, Under Secretary for International Trade, U.S. Department of Commerce. This precedent-setting initiative, potentially involving the largest ever overseas delegation of its kind led by a U.S. Government official, will serve as the capstone of a year of successful activities conducted under the auspices of the U.S.-India Commercial Dialogue, honoring the commitment of President Bush and Indian Prime Minister Manmohan Singh to revitalize bilateral trade discussions.
This is a great opportunity to get access to Indias high-level business, industry, and government representatives and opportunities to gain timely insights into the countrys trade and investment climate.
We strongly recommend and encourage you participate and benefit from this important business mission to India.
The New York Society of Security Analysts in association with USA-India Chamber of Commerce presents Investing in Asia conference.
Date: Thursday, September 28, 2006 Time: 8:30 a.m.-5:00 p.m.
Location: NYSSA, 1177 Avenue of the Americas, 2nd floor (between 45th and 46th Streets), New York, NY 10036 Photo ID required for access to the building.
Credit: PD/CE/CPE = 1
Asia has become a crucial part of the global economy, boasting three of the ten largest economiesChina, Japan, and Indiaand contributing more than 35% of world GDP. Investment has been booming in recent years, with Asia accounting for about 40% of net private capital flows into emerging markets.
The regions economy is now the fastest growing in the world, and contributes close to 50% of global growth. Aggregate GDP for Asia expanded by a robust 7.4% in 2005. This growth has been supported by a favorable external environment and continuing progress on domestic reform issues. Experts expect China and India to continue to be the fastest-growing countries in the region, with projected 2006 GDPs of 9.5% and 7.3%, respectively.
Where are the next best investment opportunities in Asia? Hear from the senior executives of growing public companies from the region, and learn what leading experts have to say about Asias economic outlook.
Sponsor
USA-India Chamber of Commerce presents Business Lunch Roundtable with David Bohigian, Assistant Secretary, International Trade Administration, U.S. Department of Commerce.
Program
Opening Remarks: Karun Rishi, President, USA-India Chamber of Commerce Introduction: Nigel Thompson, Executive Director, Merck Business Roundtable with David Bohigian, Assistant Secretary, U.S. Department of Commerce Closing Remarks: Michael Fondo, Director, Fidelity Investments
Date: Tuesday, May 2, 2006. Time: 12 pm - 2 pm
Location: Fairmont Copley Plaza Hotel, Boston
Assistant Secretary Bohigians Market Access and Compliance (MAC) division identifies and overcomes trade barriers, resolves trade policy issues, and ensures that our trading partners fully meet their obligations under our trade agreements. MAC ensures access to world markets for American companies.
MAC focuses on issues such as: Intellectual Property and Piracy, Quotas, Standards, Customs, Transparency and Contract Sanctity, National Treatment and Good Governance.
This roundtable is only for senior executives.
Event is complementary for members.
Annual International Business Forum and Networking Evening
Date: Tuesday, May 2, 2006. Registration & Seminars: 2:30 pm - 6:00 pm Networking reception: 6:30 pm - 8:00 pm Location: One Financial Center, Boston, MA 02111
The Global Economic Outlook: Implications for International Business in the Year Ahead: Christopher Probyn, Chief International Economist, State Street Corporation
Keynote speaker: David Bohigian, Assistant Secretary, US Department of Commerce
Panel discussion: Assessing & Managing Risk in the Global Marketplace
The business forum will kick off with a Global Economic Outlook seminar, which will include information on global market indicators and implications for international business in the year ahead. The forum will also include a session on Assessing and Managing Risk in the Global Marketplace, featuring panelists who will discuss techniques for assessing and mitigating various risks of doing business internationally: global security; political, economic and credit risk; intellectual property protection and commercial risks; and regulatory compliance.
Media Sponsor
Interactive lunch meeting with Dr. V.S.Seshadri, Minister (Commerce), Embassy of India
Date: Tuesday, March 14, 2006 Time: 11-45 am to 1-30 pm Location: Downtown Boston
USA-India Chamber of Commerce presents an interactive lunch meeting with Dr. V.S.Seshadri, Minister (Commerce), Embassy of India, Washington DC. He is a senior diplomat and a key person responsible for trade and exim policy issues. He is also an expert on WTO issues. This will be the first briefing nationally discussing the trade agreements signed last week during President Bush's India visit.
Agenda:
Important trade agreements signed during President Bush's India visit & its impact on US-India trade.
Opportunities in India: Best prospect sectors for US companies
Indian Budget 2006 highlights- Budget was presented to the Indian parliament on Feb 28.
USA-India Chamber of Commerce and USIBC present an Executive Luncheon Business Roundtable with Satwant Reddy, Secretary to Government of India, Ministry of Chemicals. She is the top ranking official in the ministry. Her portfolio includes the regulation of all state-owned chemical companies, pharmaceuticals, and petrochemicals. Among other things, she is tasked responsibility for formulating India ’s data exclusivity and pharmaceutical price control policies
Date: January 27, 2006 Time: 11-30 AM to 2 PM Location: Downtown Boston
It is a member’s only event for senior executives. This event is complementary for our members.
Please email to info@usaindiachamber.org if you are interested in attending.
Jan 26, 2006, 6-30 pm
Dinner meeting with Ms. Satwant Reddy, Secretary to Government of India, Ministry of Chemicals & Petrochemicals and Prof. Josh Lerner, Jacob H. Schiff Professor of Investment Banking, Harvard Business School and author of the book: 'Innovation and Its Discontents’: How Our Broken Patent System is Endangering Innovation and Progress. Exclusively for members and sponsors.
